HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pierfrancesco Marra Selected Research

Ligands

2/2017Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer.
8/2014The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pierfrancesco Marra Research Topics

Disease

8Neoplasms (Cancer)
01/2018 - 08/2008
5Triple Negative Breast Neoplasms
04/2017 - 09/2013
4Breast Neoplasms (Breast Cancer)
02/2017 - 09/2013
1Familial Exudative Vitreoretinopathies
12/2009
1Melanoma (Melanoma, Malignant)
10/2008
1Neoplasm Metastasis (Metastasis)
10/2008

Drug/Important Bio-Agent (IBA)

3Phosphotransferases (Kinase)IBA
04/2017 - 11/2016
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2017
2LigandsIBA
02/2017 - 08/2014
2Messenger RNA (mRNA)IBA
08/2014 - 09/2013
1KinesinsIBA
01/2018
1Frizzled ReceptorsIBA
02/2017
1Proteins (Proteins, Gene)FDA Link
02/2017
1Transforming Growth Factor-beta Type I ReceptorIBA
01/2017
1Transcription Factors (Transcription Factor)IBA
11/2016
1ErbB Receptors (EGF Receptor)IBA
08/2014
1DNA (Deoxyribonucleic Acid)IBA
09/2013
1MicroRNAs (MicroRNA)IBA
09/2013
1Valine (L-Valine)FDA Link
12/2009
1Membrane Proteins (Integral Membrane Proteins)IBA
12/2009
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
10/2008
1GTP Phosphohydrolases (GTPases)IBA
10/2008
1Urokinase Plasminogen Activator ReceptorsIBA
08/2008

Therapy/Procedure

3Drug Therapy (Chemotherapy)
04/2017 - 11/2016
2Therapeutics
11/2016 - 08/2014